PATENT CLAIM ANALYSIS

Application Number: 16150703
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-08
Patent Classification: ["514", "021400"]

Abstract:
This invention provides novel guanylate cyclase C (GC-C) agonists and their therapeutic use. The agonists may be used either alone or in combination with one or more additional agents.

Claim (Index 19):
A method of treating a condition that responds to enhanced cGMP levels in a subject, the method comprising administering to the subject a therapeutically effective amount of at least one peptide of  claim 1 .

Metadata:
- Claim Count in Document: 19.0
- Percentile: 97.0
- Lexical Diversity: 1.1
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14207753', '15622526', '14124282', '14124286', '13514158']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8322336405912569
- 35 USC 102 Novelty (BERT): 0.6243286689360065
- Combined Prediction Score: 0.8114431434257319
- Mean Citation Score: 551.340638
- Max Citation Score: 658.6026
- Similarity Product: 515.1967823425055

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test